News
GLP-1 weight-loss drugs are changing how people date and connect. In a nationally representative survey of 2,000 single U.S.
A study by the Evernorth Research Institute looking at national prescription drug use trends found GLP-1 use between 2023-2024 rose 84.6% in Gen Alpha (ages 14 and younger). The age group was ...
People who use GLP-1 weight loss drugs like Ozempic are more likely to suffer from severe acid reflux, or GERD, a new ...
Use of GLP-1 Drugs to Treat Overweight or Obesity Increased 587 Percent from 2019 to 2024, According to New FAIR Health Study Provided by PR Newswire May 27, 2025, 12:11:00 PM ...
After the American Academy of Pediatrics recommended the use of certain GLP-1 weight loss drugs in January of 2023, the use ...
Overpaying for GLP-1 medications is extremely common, with a new data analysis of 102,166 drugs showing that 92% of those prescriptions could have been filled at a lower price. The DoseSpot analysis ...
Surgery Still Beats Ozempic and Other GLP-1 Drugs in Real-World Weight Loss Study Patients on GLP-1 medications lost about half as much weight as participants did in clinical trials, NYU ...
Now used for type 2 diabetes, new study shows GLP-1 drugs helped people with type 1 keep blood glucose levels in a healthy range while also losing weight. Skip to Main Content.
No cancers had statistically significant adverse associations with GLP-1 use, he noted, including pancreatic cancer (HR 1.00, 95% CI 0.83-1.20) and thyroid cancer (HR 1.02, 95% CI 0.83-1.25 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results